510(k) K233606

ADVIA Centaur EBV-VCA IgM by Biokit, S.A. — Product Code LSE

K233606 is an FDA 510(k) premarket notification submitted by Biokit, S.A. for the device "ADVIA Centaur EBV-VCA IgM". The FDA issued a decision of Substantially Equivalent on August 7, 2024. The device falls under product code LSE (Epstein-Barr Virus, Other), a Class I device regulated under 21 CFR 866.3235. Biokit, S.A. has at least 10 other 510(k) clearances on record.

Clearance Details

Decision
SESE (Substantially Equivalent)
Decision Date
August 7, 2024
Date Received
November 9, 2023
Clearance Type
Traditional
Expedited Review
No
Third Party Review
No

Device Classification

Device Name
Epstein-Barr Virus, Other
Device Class
Class I
Regulation Number
866.3235
Review Panel
MI
Submission Type